A phase IV, multicentre, randomised, double-blind, single dummy, parallel group study to compare the anti-inflammatory action of Seretide™ 50 MDI b.d. with Flixotide™ 50 ug MDI b.d. plus montelukast 10 mg o.d. for 12 weeks, in adults with mild to moderate asthma who are currently taking inhaled corticosteroids but have a requirements for further therapy—Study SAM40030 (SOLTA - Seretide Or addition of a Leukotriene antagonist in the Treatment of Asthma)

Authors
Category Primary study
Year 2004
This article has no abstract
Epistemonikos ID: c08b2d9fb64e956e4cdb80f4a9233232bca44762
First added on: Sep 15, 2017